NEXTCURE, INC. Shares of Common Stock ($0.001 par value per share) SALES AGREEMENTSales Agreement • August 4th, 2023 • NextCure, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 4th, 2023 Company Industry JurisdictionNextCure, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Leerink Partners LLC (the “Agent”), as follows: